Client Alerts & Insights
Obama Signs New Federal GMO Labeling Law
August 2, 2016
Authored By:
On July 29, President Obama signed the National Bioengineered Food Disclosure Standard (S. 764) into federal law. This law will establish national standards for the labeling of food containing genetically engineered (“GE”) ingredients or genetically modified organisms (“GMOs”). The law specifically preempts any GE labeling law established by a state, including the recently enacted Vermont GMO Labeling Law.
With the signing of this law, food manufacturers no longer must abide by the Vermont labeling standards. Manufacturers may now wait for the U.S. Department of Agriculture (“USDA”) to establish the new national standards for GMO labeling. The USDA has two years to publish the national standards and print the rules of implementation.
While we do not yet know exactly what needs to be labeled, we do know that food manufacturers will be able choose the method of GMO disclosure between text, symbol, or digital link (such as a QR code that could be scanned with a smartphone). Concerning the digital link option, the Secretary of Agriculture will conduct a study on the viability and sufficiency of this disclosure method. If the study reveals that consumers will not have sufficient access to the GMO disclosure, food manufacturers will be given comparable options to disclose the information.
Currently, food manufacturers must wait for the USDA to establish the labeling standards and rules. A copy of the law can be found here.
If you have any questions on this topic please contact a member of Benesch’s Corporate & Securities Practice Group.
Latest News
The Coming State-Law Litigation Wave of 2026-27: “Subscription Trap” Class Actions
The subscription economy keeps growing—and so does the wave of class-action litigation targeting it. While the FTC’s regulatory efforts have drawn headlines, private class actions under state laws pose an even greater exposure risk.
Updates to Fees and Grace Periods for Nonimmigrant Visas
Starting September 9, 2026, the 9-11 Response Biometric Entry-Exit Fee will apply to H-1B and L-1 extension petitions filed by employers subject to the fee. Prior to the new rule, the fee was only required for (1) initial grant of status to a foreign national seeking H-1B or L-1 status and (2) a change of employer in the same status.
Third Circuit Decision Reshapes Creditor Standing in Successor Liability Disputes
The Third Circuit recently held that when determining whether a successor liability claim belongs to a bankruptcy estate, the key question is whether the claim seeks to remedy harm suffered by all creditors collectively or a unique injury suffered by a specific creditor. The fact that creditors may be permitted to bring the claim outside of bankruptcy is not, by itself, determinative.
CMS Proposes Sweeping Restrictions on Remote Patient Monitoring: The Outsourcing Ban, Reimbursement Revaluation and Potential Code Consolidation in the CY 2027 Physician Fee Schedule Proposed Rule
CMS’s CY 2027 Proposed Rule would significantly restrict Medicare reimbursement for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), including banning outsourced clinical staffing, adding new patient-relationship and initiating-visit requirements, reducing certain reimbursement rates, and exploring consolidation of existing billing codes.